Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000407086

Medchemexpress LLC Fenoldopam mesylate | 67227-57-0 | 99.94% | 5 MG
SDP

Catalog No. 5000407086
Encompass_Preferred

Fenoldopam mesylate (SKF-82526) is a D1 receptor agonist and a novel lysine-specific demethylase 1 (LSD1) inhibitor. It exhibits anti-hypertensive effects, anti-cancer cell proliferation activity, and can induce cell apoptosis. This compound is suitable for research use only.

  • Functions as a D1 receptor agonist
  • Acts as a novel LSD1 inhibitor with an IC50 of 0.8974 μM
  • Exhibits anti-hypertensive effects
  • Demonstrates anti-cancer cell proliferation activity
  • Can induce cell apoptosis
  • Shows antiproliferative activity against RCC cell lines
  • Induces cell apoptosis in ACHN cells in a dose-dependent manner

Catalog No. 50-004-07086 Supplier Medchemexpress LLC Supplier No. HYB0735A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Fenoldopam mesylate (SKF-82526) is a D1 receptor agonist and a novel lysine-specific demethylase 1 (LSD1) inhibitor. It exhibits anti-hypertensive effects, anti-cancer cell proliferation activity, and can induce cell apoptosis. This compound is suitable for research use only.

  • Functions as a D1 receptor agonist
  • Acts as a novel LSD1 inhibitor with an IC50 of 0.8974 μM
  • Exhibits anti-hypertensive effects
  • Demonstrates anti-cancer cell proliferation activity
  • Can induce cell apoptosis
  • Shows antiproliferative activity against RCC cell lines
  • Induces cell apoptosis in ACHN cells in a dose-dependent manner

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.